Related content

Complete molar pregnancy with very low serum hCG

By Banerjee A. K.   Gyesi-Appiah A.   McCullough W. L.  

Journal of Obstetrics & Gynaecology, Vol. 29, Iss. 3, 2009-04 ,pp. : 268-269

Informa Healthcare

Access to resources Recommend Favorite

Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation

By Petignat P.   Boulvain M.   Vassilakos P.  

Obstetrics and Gynecology, Vol. 102, Iss. 3, 2003-09 ,pp. : 642-643

Elsevier

Access to resources Recommend Favorite

Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation

By Kohorn E.I.  

Obstetrics and Gynecology, Vol. 102, Iss. 6, 2003-12 ,pp. : 1417-1417

Elsevier

Access to resources Recommend Favorite

Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluationReply

By Feltmate C.M.   Bartorsi J.   Fulop V.   Goldstein D.P.   Berkowitz R.S.  

Obstetrics and Gynecology, Vol. 102, Iss. 3, 2003-09 ,pp. : 643-643

Elsevier

Access to resources Recommend Favorite

Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur(R)), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome

By Regidor P.-A.   Regidor M.   Kato K.   Bier U.W.   Buhler K.   Schindler A.E.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 73, Iss. 2, 1997-06 ,pp. : 153-160

Elsevier

Access to resources Recommend Favorite